Myofunctional Therapy for Children With OSA
A legfontosabb adatok
- Ki végzi
- Chinese University of Hong Kong
- Hol
- Hongkong1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 174 fő, tervezett
- Kezdés
- 2025. dec. 1.
- Várható befejezés
- 2028. dec. 31.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport nem kap vizsgálati kezelést, összehasonlításként.
- A vizsgált kezelések
- Myofunctional therapy
- A regiszteradat frissítve
- 2026. október 21.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for children aged 6-12 years with obstructive sleep apnoea, where breathing stops or gets shallow during sleep. It tests mouth and face muscle exercises, with remote coaching, against standard care.
- Életkor
- 6 to 12 years
- Nem
- All sexes
- A betegség stádiuma
- Obstructive sleep apnoea shown by a sleep study (oAHI ≥ 1/hour). The child must snore 3 nights or more per week, plus a sign such as mouth breathing or pauses in breathing during sleep. Children whose sleep apnoea stayed after standard treatment, shown by a repeat sleep study, can join.
- Korábbi kezelés
- Children can join after standard treatments such as removal of tonsils and adenoids, if sleep apnoea remains.
- Biomarker vagy leletérték
- Sleep study (polysomnography) result of oAHI ≥ 1/hour.
A részvétel fő kizáró okai
- Genetic, syndrome-related or metabolic disease
- Inborn or acquired nerve and muscle disease
- Skull and face abnormalities from a syndrome, or past skull or face surgery
- Severe developmental delay (developmental age below 66% of real age)
- Planned other treatment, such as tonsil and adenoid removal, breathing pressure machine or braces
A regiszter feltételei, szó szerint
Mind a 8 feltétel megnézéseKevesebb
Ki vehet részt
- Children aged 6-12 years, with this age range, children start to have a greater ability to understand and follow instructions, making them more likely to comply and cooperate with the treatment procedures, and at the same time this age range remains a critical and modifiable developmental window when interventions can address underlying orofacial muscle and respiratory muscle dysfunctions and enhance the potential for long-term benefits
- Diagnosed with OSA based on clinical evaluation and polysomnography (oAHI ≥ 1/hour). The clinical evaluation will involve assessing the presence of habitual snoring, which is defined as snoring occurring 3 nights or more per week on average as reported by parents or caregivers, and any of the following features suggestive of SDB such as oral breathing, respiratory pauses, observed apnoeas, or increased work of breathing during sleep. Children with persistent OSA, documented by repeat PSG, can be included after receiving standard treatments (such as adenotonsillectomy treatment)
- Informed consent from a parent or a legal guardian
Ki nem vehet részt
- Syndromal craniofacial abnormalities or previous craniofacial surgery
- Children with OSA who are indicated for and will receive other treatments such as adenotonsillectomy, positive airway pressure therapy or orthodontic treatment
- Genetic, syndromal, or metabolic disease
- Congenital or acquired neuromuscular disease
- Severe developmental delay (developmental or functional age <66% of chronological age)
A fő feltételek kérdésként
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 6 és 12 év között vagy?
Ez a vizsgálat jelenleg itt érhető el: Hongkong.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
Myofunctional therapy (MFT) has been proposed as an adjunctive therapy for obstructive sleep apnoea (OSA) in children.
A teljes eredeti leírásKevesebb
Some studies have reported improved sleep parameters and reduced oral breathing after MFT. However, the level of evidence in these studies is limited, with most being case series or case-control studies. There have been only a few randomised controlled trials (RCTs), and these studies have had limitations such as low response rate, short follow-up periods, and the existing evidence does not adequately address the potential clinical benefits and the impact on craniofacial structure. Additionally, there is a lack of evidence regarding the effectiveness of additional measures, such as remote guidance and supervision, in improving treatment outcomes in children. Therefore, there is a need for further research to address these gaps and provide more robust evidence on the efficacy of MFT in children with OSA. The objective of this study is to investigate the efficacy of MFT in children with OSA through a multi-centre randomised controlled trial (RCT). 174 children aged 6-12 years old with OSA will be recruited and randomly assigned to either the intervention or control group. All children will undergo standardised evaluation at baseline and follow-up visits. In the intervention arm, a 24-week myofunctional therapy targeting orofacial MFT, breathing, and postural re-education, with incorporation of telemedicine for remote training and monitoring. In the control arm, children will receive standard care without MFT. The primary outcome measure will be obstructive apnoea hypopnoea index measured by polysomnography. Secondary outcome measures will be the oral breathing pattern, OSA-related symptoms, and quality of life. The treatment effect on outcomes will be examined using a mixed-effects model with an intention-to-treat approach. Subgroup analyses will explore potential effect modification by important participant characteristics, such as OSA severity and compliance. This study will generate evidence-based information regarding the efficacy of MFT in children with OSA and will inform clinical practice.
A vizsgálat 2 csoportja
- Intervention groupA vizsgált kezelés
Participants in the intervention group will undergo a MFT programme with telemedicine support.
Kezelés: Myofunctional therapy
- ControlsNincs vizsgálati kezelés, összehasonlításként
Participants in the control group will receive standard care, such as anti-inflammatory medications if indicated, without the Myofunctional therapy .
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Myofunctional Therapy for Children With Obstructive Sleep Apnoea - a Multi-centre Randomised Controlled Trial
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- Kérdések a feltételekről
- Forrás: NCT07249944: ki vehet részt
- A regiszteradat frissítve
- 2026. október 21.